Pharmaceutical FDA Inspections
Pharmaceutical FDA Inspection Readiness and Compliance Support
Former FDA investigators help pharmaceutical manufacturers, CMOs, packagers, laboratories, and suppliers prepare for inspections, respond to observations, and keep cGMP records ready for review.
Pharmaceutical inspection readiness
Pharmaceutical Support
FDA Pharmaceutical Services and Product Areas
Pharmaceutical inspections put cGMP systems, batch records, laboratory controls, validation, suppliers, data integrity, complaints, and CAPA evidence under review.
cGMP Inspection Readiness Audits
Former FDA investigators review drug quality systems, batch records, deviations, validation files, laboratory controls, and facility records before FDA arrives.
- 21 CFR Parts 210 and 211
- Batch record review
- Facility walkthroughs
483 and Warning Letter Response
Pharma teams get help with observation analysis, root cause work, CAPA plans, response drafting, and follow-up inspection preparation.
- Observation analysis
- CAPA evidence
- Response support
Pre-Approval Inspection Prep
NDA, ANDA, BLA, and supplemental application sites need inspection plans tied to process validation, methods, batch data, and quality records.
- PAI planning
- Application records
- Validation review
Data Integrity and Part 11
Electronic records, audit trails, laboratory data, access controls, and required signatures need records FDA can trust.
- Audit trail checks
- Part 11 review
- ALCOA records
Sterile Drug Manufacturing
Sterile drug sites need aseptic process controls, environmental monitoring, media fills, cleanroom records, and contamination response plans.
- Aseptic operations
- EM program review
- Sterility assurance
OTC and Prescription Drugs
OTC and prescription products need cGMP records, labeling support, complaint files, recall procedures, and manufacturing controls.
- Rx and OTC products
- Label support
- Complaint records
API and Excipient Suppliers
API and excipient firms need supplier qualification, laboratory controls, data integrity checks, and traceable material records.
- API cGMP review
- Supplier files
- Lab controls
Quality Systems and Risk Review
Quality systems need management review, deviation control, change control, annual product reviews, supplier oversight, and training evidence.
- Quality system review
- Change controls
- Training records
Why Work With Us
Pharmaceutical Inspection Support Built Around FDA Expectations
Our consultants focus on the records FDA asks to see, from manufacturing and laboratory data to validation, deviations, CAPA, supplier oversight, and data integrity evidence.
cGMP Record Readiness
Prepare batch records, deviations, laboratory data, validation files, APRs, and production evidence.
Learn MorePAI and Surveillance Support
Prepare application sites, commercial sites, and contract facilities for FDA inspection questions.
Learn MoreCAPA and Data Integrity
Connect findings to corrective actions, owners, dates, audit trails, and evidence FDA can review.
Learn MoreCMO and Global Site Support
Support manufacturers, CMOs, packagers, laboratories, and foreign sites preparing for FDA review.
Learn MoreCommon Questions
Frequently Asked Questions
FDA may inspect drug facilities for routine surveillance, pre-approval review, pre-license review, for-cause concerns, recalls, complaints, import issues, or follow-up to prior observations.
Finished pharmaceutical manufacturers are inspected against cGMP requirements in 21 CFR Parts 210 and 211, along with other product-specific and record requirements.
Common findings include weak investigations, poor CAPA evidence, data integrity gaps, incomplete batch records, laboratory control issues, validation gaps, and supplier control problems.
Yes. Teams can get help with root cause analysis, CAPA planning, response drafting, evidence packages, and preparation for FDA follow-up.